跳至主要内容
临床试验/NCT00466622
NCT00466622已完成3 期

Uterine Artery Blood Flow in Pregnant Women With Polycystic Ovary Syndrome(PCOS)Treated With Metformin - a Substudy to The PregMet Study

Norwegian University of Science and Technology1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2007年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
48
试验地点
1
主要终点
Pulsatility index of the uterine artery

研究概览

简要总结

FlowMet study is a "sub-study" of the PregMet study (registered in 2005).

The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregnant PCOS women. The participants will be examined with ultrasound Doppler in gestational week 10-13:

  1. before and 3h after the first tablet intake of metformin/placebo
  2. and 10-14 days after inclusion in the trial
  3. blood flow in the umbilical artery and fetal cerebral artery in gestational week 24.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Same as in the PregMet study. As this study is a sub-study/extended study of the PregMet study, ONLY those included in the PregMet study (NCT00159536) can participate.

排除标准

  • Same as in the PregMet study

研究组 & 干预措施

1

Experimental

Metformin 1000mg x 2 daily. Orally. From Weifa

干预措施: Metformin (Drug)

2

Placebo Comparator

Placebo 2 tablets x 2 daily. Orally From Weifa

干预措施: Placebo (Drug)

结局指标

主要结局

Pulsatility index of the uterine artery

时间窗: up to delivery

3 hrs before and after drug intake, 2 weeks after inclusion, and during medication

次要结局

  • Blood flow in the umbilical artery and fetal cerebral artery(24 weeks gestational)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验